Chepelare, Bulgaria

Radoslav A Kefilev

This inventor holds 2 USPTO granted patents and 3 published patent applications and 1 EPO patent. Top assignees: Btl Healthcare Technologies A.s., Milara Incorporated. Active years: 2019-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Radoslav A Kefilev. Retrieved from https://idiyas.com/inventor/radoslav-a-kefilev

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 2 

% Patents Active = 50.0

 

Average Co-Inventor Count = 6.0

ph-index = 1


Company Filing History:


Years Active: 2019-2026

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Inventor Radoslav A Kefilev - Revolutionizing Technology in Chepelare, BG

Introduction: Radoslav A Kefilev is a visionary inventor based in Chepelare, Bulgaria, known for his groundbreaking contributions to the field of technology.

Latest Patents: Radoslav A Kefilev holds several patents in the areas of artificial intelligence, renewable energy, and sustainable transportation, showcasing his innovative approach to solving modern challenges.

Career Highlights: With a career spanning over two decades, Radoslav A Kefilev has worked with leading tech companies to develop cutting-edge solutions that have had a significant impact on various industries.

Collaborations: Throughout his career, Radoslav A Kefilev has collaborated with top researchers, engineers, and scientists from around the world, fostering a culture of innovation and excellence in all his projects.

Conclusion: Radoslav A Kefilev's relentless pursuit of innovation and his passion for creating a better future through technology make him a true pioneer in the field of inventions.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…